The effects of microenvironment and internal programming on plasma cell survival

International Immunology

Volumn 19, Issue 7, 2007, Pages 837-846

  Minges Wols, Heather A ^a,b   Ippolito, Jill A ^b   Yu, Zheng ^b   Palmer, Jessica L ^b   White, Fletcher A ^b   Le, Phong T ^b   Witte, Pamela L ^b  

^a and Social Sciences   (United States)

^b LOYOLA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Antibody; Bone marrow; CXCL12; Plasma cell; Stromal cell

Indexed keywords

B CELL ACTIVATING FACTOR BELONGING TO THE TUMOR NECROSIS FACTOR FAMILY; INTERLEUKIN 6; INTERLEUKIN 7; STEM CELL FACTOR; STROMAL CELL DERIVED FACTOR 1; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BONE MARROW; CELL ISOLATION; CELL SURVIVAL; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; IMMUNIZATION; IN VITRO STUDY; LYMPH NODE; MOUSE; NONHUMAN; PHENOTYPE; PLASMA CELL; PRIORITY JOURNAL; SPLEEN; STROMA CELL;

ANIMALS; BONE MARROW CELLS; CELL SURVIVAL; FEMALE; LYMPH NODES; MICE; MICE, INBRED BALB C; PLASMA CELLS; SPLEEN;

EID: 34547739598     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxm051     Document Type: Article

References (53)

1. Ho, F., Lortan, J. E., MacLennan, I. C. and Khan, M. 1986. Distinct short-lived and long-lived antibody-producing cell populations. Eur. J. Immunol. 16:1297.
2. Jacob, J., Kassir, R. and Kelsoe, G. 1991. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. I. The architecture and dynamics of responding cell populations. J. Exp. Med. 173:1165.
3. Jacob, J. and Kelsoe, G. 1992. In situ studies of the primary immune response to (4-hydroxy-3-nitrophenyl)acetyl. II. A common clonal origin for periarteriolar lymphoid sheath-associated foci and germinal centers. J. Exp. Med. 176:679.
4. Dilosa, R. M., Maeda, K., Masuda, A., Szakal, A. K. and Tew, J. G. 1991. Germinal center B cells and antibody production in the bone marrow. J. Immunol. 146:4071.
5. Benner, R., Hijmans, W. and Haaijman, J. J. 1981. The bone marrow: The major source of serum immunoglobulins, but still a neglected site of antibody formation. Clin. Exp. Immunol. 46:1.
6. Slifka, M. K., Antia, R., Whitmire, J. K. and Ahmed, R. 1998. Humoral immunity due to long-lived plasma cells. Immunity 8:363.
7. Manz, R. A., Thiel, A. and Radbruch, A. 1997. Lifetime of plasma cells in the bone marrow. Nature 388:133.
8. Shapiro-Shelef, M., Lin, K. I., Savitsky, D., Liao, J. and Calame, K. 2005. Blimp-1 is required for maintenance of long-lived plasma cells in the bone marrow. J. Exp. Med. 202:1471.
9. Iwakoshi, N. N., Lee, A. H., Vallabhajosyula, P., Otipoby, K. L., Rajewsky, K. and Glimcher, L. H. 2003. Plasma cell differentiation and the unfolded protein response intersect at the transcription factor XBP-1. Nat. Immunol. 4:321.
10. Cenci, S., Mezghrani, A., Cascio, P. et al. 2006. Progressively impaired proteasomal capacity during terminal plasma cell differentiation. EMBO J. 25:1104.
11. Cassese, G., Arce, S., Hauser, A. E. et al. 2003. Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals. J. Immunol. 171:1684.
12. Ingold, K., Zumsteg, A., Tardivel, A. et al. 2005. Identification of proteoglycans as the APRIL-specific binding partners. J. Exp. Med. 201:1375.
13. Minges Wols, H. A., Underhill, G. H., Kansas, G. S. and Witte, P. L. 2002. The role of bone marrow-derived stromal cells in the maintenance of plasma cell longevity. J. Immunol. 169:4213.
14. O'Connor, B. P., Raman, V. S., Erickson, L. D. et al. 2004. BCMA is essential for the survival of long-lived bone marrow plasma cells. J. Exp. Med. 199:91.
15. Ramanujam, M., Wang, X., Huang, W. et al. 2006. Similarities and differences between selective and nonselective BAFF blockade in murine SLE. J. Clin. Invest. 116:724.
16. Tokoyoda, K., Egawa, T., Sugiyama, T., Choi, B. I. and Nagasawa, T. 2004. Cellular niches controlling B lymphocyte behavior within bone marrow during development. Immunity 20:707.
17. Cheung, W. C. and Van Ness, B. 2002. Distinct IL-6 signal transduction leads to growth arrest and death in B cells or growth promotion and cell survival in myeloma cells. Leukemia 16:1182.
18. Hardin, J., MacLeod, S., Grigorieva, I. et al. 1994. Interleukin-6 prevents dexamethasone-induced myeloma cell death. Blood 84:3063.
19. Jelinek, D. F. 1999. Mechanisms of myeloma cell growth control. Hematol. Oncol. Clin. North. Am. 13:1145.
20. Kawano, M., Hirano, T., Matsuda, T. et al. 1988. Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas. Nature 332:83.
21. Roldan, E. and Brieva, J. A. 1991. Terminal differentiation of human bone marrow cells capable of spontaneous and high-rate immunoglobulin secretion: Role of bone marrow stromal cells and interleukin 6. Eur. J. Immunol. 21:2671.
22. Witte, P. L., Frantsve, L. M., Hergott, M. and Rahbe, S. M. 1993. Cytokine production and heterogeneity of primary stromal cells that support B lymphopoiesis. Eur. J. Immunol. 23:1809.
23. Whitlock, C. A. and Witte, O. N. 1982. Long-term culture of B lymphocytes and their precursors from murine bone marrow. Proc. Natl Acad. Sci. USA 79:3608.
24. Gray Parkin, K., Stephan, R. P., Apilado, R. G. et al. 2002. Expression of CD28 by bone marrow stromal cells and its involvement in B lymphopoiesis. J. Immunol. 169:2292.
25. Skalli, O., Ropraz, P., Trzeciak, A., Benzonana, G., Gillessen, D. and Gabbiani, G. 1986. A monoclonal antibody against alpha-smooth muscle actin: A new probe for smooth muscle differentiation. J. Cell Biol. 103:2787.
26. Schmitt-Graff, A., Skalli, O. and Gabbiani, G. 1989. Alpha-smooth muscle actin is expressed in a subset of bone marrow stromal cells in normal and pathological conditions. Virchows Arch. B Cell Pathol. Incl. Mol. Pathol. 57:291.
27. Skalli, O., Schurch, W., Seemayer, T. et al. 1989. Myofibroblasts from diverse pathologic settings are heterogeneous in their content of actin isoforms and intermediate filament proteins. Lab. Invest. 60:275.
28. Bonanno, E., Ercoli, L., Missori, P., Rocchi, G. and Spagnoli, L. G. 1994. Homogeneous stromal cell population from normal human adult bone marrow expressing alpha-smooth muscle actin filaments. Lab. Invest 71:308.
29. Sze, D. M., Toellner, K. M., Garcia de Vinuesa, C., Taylor, D. R. and MacLennan, I. C. 2000. Intrinsic constraint on plasmablast growth and extrinsic limits of plasma cell survival. J. Exp. Med. 192:813.
30. McHeyzer-Williams, L. J., Cool, M. and McHeyzer-Williams, M. G. 2000. Antigen-specific B cell memory: Expression and replenishment of a novel B220(-) memory B cell compartment. J. Exp. Med. 191:1149.
31. Sanderson, R. D., Lalor, P. and Bernfield, M. 1989. B lymphocytes express and lose syndecan at specific stages of differentiation. Cell Regul. 1:27.
32. Young, B. and Heath, J. W. 2000. Wheater's Functional Histology: A Text And Colour Atlas. 4th edn. Churchill Livingstone, St. Louis, MO.
33. Sanders, V. M., Baker, R. A., Ramer-Quinn, D. S., Kasprowicz, D. J., Fuchs, B. A. and Street, N. E. 1997. Differential expression of the beta2-adrenergic receptor by Th1 and Th2 clones: Implications for cytokine production and B cell help. J. Immunol. 158:4200.
34. Kamperschroer, C. and Quinn, D. G. 1999. Quantification of epitope-specific MHC class-II-restricted T cells following lymphocytic choriomeningitis virus infection. Cell. Immunol. 193:134.
35. Shaffer, A. L., Lin, K. I., Kuo, T. C. et al. 2002. Blimp-1 orchestrates plasma cell differentiation by extinguishing the mature B cell gene expression program. Immunity 17:51.
36. Underhill, G. H., Minges Wols, H. A., Fornek, J. L., Witte, P. L., Kansas, G. S. and Minges-Wols, H. A. 2002. IgG plasma cells display a unique spectrum of leukocyte adhesion and homing molecules. Blood 99:2905.
37. Medina, F., Segundo, C., Campos-Caro, A., Gonzalez-Garcia, I. and Brieva, J. A. 2002. The heterogeneity shown by human plasma cells from tonsil, blood, and bone marrow reveals graded stages of increasing maturity, but local profiles of adhesion molecule expression. Blood 99:2154.
38. Turner, C. A. Jr, Mack, D. H. and Davis, M. M. 1994. Blimp-1, a novel zinc finger-containing protein that can drive the maturation of B lymphocytes into immunoglobulin-secreting cells. Cell 77:297.
39. Angelin-Duclos, C., Cattoretti, G., Chang, D. H. et al. 1999. Role of B-lymphocyte-induced maturation protein-1 in terminal differentiation of B cells and other cell lineages. Cold Spring Harb. Symp. Quant. Biol. 64:61.
40. Lin, K. I., Angelin-Duclos, C., Kuo, T. C. and Calame, K. 2002. Blimp-1-dependent repression of Pax-5 is required for differentiation of B cells to immunoglobulin M-secreting plasma cells. Mol. Cell. Biol. 22:4771.
41. Garcia De Vinuesa, C., Gulbranson-Judge, A., Khan, M. et al. 1999. Dendritic cells associated with plasmablast survival. Eur. J. Immunol. 29:3712.
42. Kawano, M. M., Mihara, K., Huang, N., Tsujimoto, T. and Kuramoto, A. 1995. Differentiation of early plasma cells on bone marrow stromal cells requires interleukin-6 for escaping from apoptosis. Blood 85:487.
43. Brieva, J. A., Roldan, E., De la Sen, M. L. and Rodriguez, C. 1991. Human in vivo-induced spontaneous IgG-secreting cells from tonsil, blood and bone marrow exhibit different phenotype and functional level of maturation. Immunology 72:580.
44. Jacob, J., Kelsoe, G., Rajewsky, K. and Weiss, U. 1991. Intraclonal generation of antibody mutants in germinal centres. Nature 354:389.
45. Ngo, V. N., Tang, H. L. and Cyster, J. G. 1998. Epstein-Barr virus-induced molecule 1 ligand chemokine is expressed by dendritic cells in lymphoid tissues and strongly attracts naive T cells and activated B cells. J. Exp. Med. 188:181.
46. Donaldson, S. L., Kosco, M. H., Szakal, A. K. and Tew, J. G. 1986. Localization of antibody-forming cells in draining lymphoid organs during long-term maintenance of the antibody response. J. Leukoc. Biol. 40:147.
47. Funk, P. E., Stephan, R. P. and Witte, P. L. 1995. Vascular cell adhesion molecule 1-positive reticular cells express interleukin-7 and stem cell factor in the bone marrow. Blood 86:2661.
48. Hauser, A. E., Debes, G. F., Arce, S. et al. 2002. Chemotactic responsiveness toward ligands for CXCR3 and CXCR4 is regulated on plasma blasts during the time course of a memory immune response. J. Immunol. 169:1277.
49. Wehrli, N., Legler, D. F., Finke, D. et al. 001. Changing responsiveness to chemokines allows medullary plasmablasts to leave lymph nodes. Eur. J. Immunol. 31:609.
50. Hargreaves, D. C., Hyman, P. L., Lu, T. T. et al. 2001. A coordinated change in chemokine responsiveness guides plasma cell movements. J. Exp. Med. 194:45.
51. Underhill, G. H., George, D., Bremer, E. G. and Kansas, G. S. 2003. Gene expression profiling reveals a highly specialized genetic program of plasma cells. Blood 101:4013.
52. Kopf, M., Baumann, H., Freer, G. et al. 1994. Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature 368:339.
53. Moreaux, J., Cremer, F. W., Reme, T. et al. 2005. The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature. Blood 106:1021.